Biopharmaceutical company developing novel gene-based methods to treat human diseases.
Bioventure company established at Nihon University School of Medicine. Focuses on the use of antisense nucleotides and ribozymes for the treatment of cardiovascular and renal diseases.
An emerging biopharmaceutical company developing novel gene therapies for diseases where local delivery of a therapeutic gene has potential benefits over currently available treatments. New product development initiatives have been formalized for coronary artery disease with BioBypass angiogen, restenosis prevention and cancer.
A leader in the development of gene therapy products to treat a variety of cancers.
Focuses on developing gene transfer technologies for human gene therapy, gene-based immunotherapy, and gene-based drug discovery for cancer, AIDS, neurodegenerative and cardiovascular disease.
Gene therapy company based in France is developing products for cancer and cystic fibrosis. Vector platforms include adenovirus, retrovirus, vaccinia virus, cellular and synthetic vectors.
Developing gene-based therapeutics or "gene medicines" for the treatment of certain cancers, neuromuscular, cardiovascular, rheumatological and pulmonary diseases.
Company focusing on the development of therapeutic lentivirus vector technology for the delivery of short interfering RNA molecules.
A biotechnology company with a primary interest in cancer gene therapy.
Biotechnology company focused on the development of low-density lipoproteins as gene delivery systems.
Science /
Biology /
Biotechnology /
Products_and_Services
|